Search
for
Sort by
Research 211–240 of 1000+
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Alopecia areata: Pathogenesis and treatment
- Topical minoxidil in the treatment of alopecia areata.
- Alopecia areata: a new treatment plan
- JAK Inhibitors for Treatment of Alopecia Areata
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia Areata: Treatment of Today and Tomorrow
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Bimatoprost in the treatment of eyelash universalis alopecia areata
- Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Oral Zinc Sulphate in Treatment of Alopecia Areata (Double Blind; Cross-Over Study)
- Topical minoxidil in the treatment of alopecia areata.
- New aspects of the treatment of alopecia areata
- Platelet-Rich Plasma in Alopecia Areata—A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- Oral tofacitinib for the treatment of alopecia areata in pediatric patients
- Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers
- Evidence-based treatment of alopecia areata
- Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
- Mesalazine in the treatment of extensive alopecia areata: A new therapeutic option?
- Systemic Steroids for Treatment of Alopecia Areata
- Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair